洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

首页 临床进展 Effect of Topical NSAIDs (Diclofenac 0.1%, Nepafenac 0.1%, Nepafenac 0.3%) on Pain Management During Intravitreal Injections: A Prospective, Non-Randomized, Case-Control Trial

【ChiCTR2500110461】Effect of Topical NSAIDs (Diclofenac 0.1%, Nepafenac 0.1%, Nepafenac 0.3%) on Pain Management During Intravitreal Injections: A Prospective, Non-Randomized, Case-Control Trial

查看原文
立即下载
基本信息
登记号

ChiCTR2500110461

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2025-10-14

临床申请受理号

/

靶点

/

适应症

Pain associated with Intravitreal Injections

试验通俗题目

Effect of Topical NSAIDs (Diclofenac 0.1%, Nepafenac 0.1%, Nepafenac 0.3%) on Pain Management During Intravitreal Injections: A Prospective, Non-Randomized, Case-Control Trial

试验专业题目

Effect of Topical NSAIDs on Pain Management During Intravitreal Injections

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

44000

联系人通讯地址
请登录查看
临床试验信息
试验目的

Primary objective of the study is to measure the effect of the addition of pre-operative topical NSAID on perceived pain during intravitreal injection procedures

试验分类
请登录查看
试验类型

非随机对照试验

试验分期

其它

随机化

None

盲法

/

试验项目经费来源

Self-funded

试验范围

/

目标入组人数

100

实际入组人数

/

第一例入组时间

2025-10-17

试验终止时间

2026-02-20

是否属于一致性

/

入选标准

1. Age 18 years or older; 2. Scheduled to receive a monocular intravitreal injection of an anti-VEGF agent; 3. Able to understand, consent, and use the Visual Analog Scale for pain reporting.；

排除标准

1. Known hypersensitivity or allergy to proparacaine, diclofenac, nepafenac, or any other NSAID; 2. Presence of active or severe ocular surface disease (e.g., keratitis, severe dry eye); 3. History of ocular surgery within the past 3 months; 4. Concurrent use of any systemic or topical NSAIDs for any other medical reason; 5. A diagnosed anxiety disorder, severe needle phobia, or inability to comprehend the study protocol.；

研究者信息
研究负责人姓名
请登录查看
试验机构

Fauji Foundation Hospital Rawalpindi, Pakistan

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

44000

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

Fauji Foundation Hospital Rawalpindi, Pakistan的其他临床试验

更多

Fauji Foundation Hospital Rawalpindi, Pakistan / Foundation University Medical College Islamabad, Pakistan的其他临床试验

更多

最新临床资讯

更多
摩熵医药企业版
50亿+条医药数据随时查
7天免费试用
体验产品